scispace - formally typeset
Journal ArticleDOI

Long-term Consequences of Kawasaki Disease A 10- to 21-Year Follow-up Study of 594 Patients

Reads0
Chats0
TLDR
The incidence of coronary aneurysm in acute Kawasaki disease was 25%, 55% of which showed regression, and during follow-up, ischemic heart disease developed in 4.7% and myocardial infarction in 1.9%.
Abstract
Background The long-term consequences of the cardiovascular sequelae in Kawasaki disease remain uncertain. Methods and results We identified 594 consecutive children with acute Kawasaki disease between 1973 and 1983, and this cohort was followed up for 10 to 21 years (mean, 13.6 years). In all patients, we evaluated coronary lesions by coronary angiography just after the acute stage. One hundred and forty-six patients (24.6%) were diagnosed as having coronary aneurysms. A second angiogram was performed 1 to 2 years later in all 146 patients who previously had coronary aneurysms, which demonstrated that 72 (49.3%) of these 146 had regression in the coronary aneurysm. A third angiogram was performed for 62 patients, a fourth for 29, and a fifth for 17. By 10 to 21 years after the onset of the illness, stenosis in the coronary aneurysm had developed in 28 patients. Myocardial infarction occurred in 11 patients, 5 of whom died. In the 26 patients with giant coronary aneurysms, stenotic lesions developed in 12, and no regression occurred. The 448 patients with normal findings at the first angiogram subsequently never developed any abnormal cardiac findings. Systemic artery aneurysms developed in 13 patients (2.2%), and valvular heart disease appeared in 7 (1.2%). Conclusions The incidence of coronary aneurysm in acute Kawasaki disease was 25%, 55% of which showed regression. During follow-up, ischemic heart disease developed in 4.7% and myocardial infarction in 1.9%. Death occurred in 0.8%.

read more

Citations
More filters
Journal ArticleDOI

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

TL;DR: These recommendations provide updated and best evidence-based guidance to healthcare providers who diagnose and manage Kawasaki disease, but clinical decision making should be individualized to specific patient circumstances.
Journal ArticleDOI

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

TL;DR: Children diagnosed after the SARS-CoV-2 epidemic began showed evidence of immune response to the virus, were older, had a higher rate of cardiac involvement, and features of MAS, and a similar outbreak of Kawasaki-like disease is expected in countries involved in the SEMS epidemic.
References
More filters
Journal ArticleDOI

A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan

TL;DR: Recently, rickettsia-like bodies were found by electron microscopy in biopsy specimens from the skin and lymph nodes of the patients, leading us to believe that this clinical picture is a new clinical entity.
Book

Kawasaki Disease

Hiroshisa Kato, +1 more
Journal ArticleDOI

High-dose intravenous gammaglobulin for Kawasaki disease.

TL;DR: High-dose IVGG seems to reduce the frequency of coronary artery abnormalities in patients with Kawasaki disease, and this lesion was confirmed in 1 of the 6 cases in the IVGG group and in 11 of the 19 controls.
Related Papers (5)